Controversies in biomedical research
28 March 2006 10:00 - 17:30 includes buffet lunch
RSS, 12 Errol St, London EC1Y 8LX
Registration is required. Please use the booking form to register for
this meeting at:
http://www.rss.org.uk/rssadmin/uploads/387239_Booking Form - MS 28.03.06.doc
FEES (including lunch, tea and coffee):
£45 for non RSS fellows
£30 for RSS fellows
£25 for CStats
PROGRAMME:
Chronology of clinically important cardiovascular event data in the
Rofecoxib (VIOXX) development programme, RAY BAIN (Merck)
The withdrawal of COX-2 inhibitors: a regulatory viewpoint, LESLEY WISE
(MHRA)
Do Cox-2 inhibitors and NSAI|Ds cause atherothrombosis? A meta-analysis
of randomised trials, COLIN BAIGENT (CTSU)
Discussion: What lessons can we learn from the withdrawal of Cox-2
inhibitors? STUART POCOCK (LSHTM), LUCIEN ABENHEIM (Paris)
BiDil, subgroup analyses, and the limits of evidence-based medicine,
GEORGE ELLISON (SGHMS)
Discussion: BiDil and subgrouping
Are these data real? STEPHEN EVANS (LSHTM)
Suspected research fraud: difficulties of getting at the truth, CAROLINE
WHITE (journalist)
Some personal experiences, DOUG ALTMAN (Centre for Statistics in
Medicine, Oxford)
Editorial bullying?, DAMIEN DOWNING (Journal of Nutritional and
Environmental Medicine)
General discussion
|